Numeric — the AI-powered accounting automation company with teams in San Francisco, New York, and London — has secured $51 million in Series B funding, bringing total capital raised to $89 million.
UK-based Vyntelligence has raised $30 million in Series B funding to scale its AI-powered video intelligence platform, with a strong focus on expanding operations in the United States.
Financial automation startup Dost has entered the UK market after closing a £6 million Series A round led by Octopus Ventures, marking the company’s biggest expansion since its founding.
When the COVID lockdowns hit, Emm founder Jenny Button noticed a gap. Devices like Oura and Whoop could track sleep, stress, and recovery — but nothing offered meaningful insights into one of the most fundamental aspects of women’s health: the menstrual cycle. “It seemed crazy to me,” she told TechCrunch.
European life sciences venture capital firm Medicxi has closed Medicxi V, a €500 million fund dedicated to backing biotech companies with clear product visions and a focus on improving patient care.
Sofinnova Partners, one of Europe’s leading life sciences venture capital firms, has closed Sofinnova Capital XI at €650 million ($750 million) — well above its initial target.
London-based payments platform Zilch has raised more than €150 million ($175 million) in a new mix of debt and equity funding, positioning the company to scale aggressively across the UK and EMEA.
T-Therapeutics, a UK biotech developing next-generation T cell receptor (TCR) therapies for cancer and autoimmune diseases, has expanded its Series A round with an additional €27.5 million ($32 million) in funding.
